Professor Allister Vale – President
Dr Tim Nicholson – Hon. Secretary
Professor Albert Ferro – Hon. Treasurer
Professor Sir Peter Barnes FRS – Member
Dr Jan Willem Elte – Member
Mr Wade Dimitri – Member
Dr Kerri Baker – Member
Dr Neil Dewhurst – Member
Dr Helen Oxenham – Member
FPM Journals
Postgraduate Medical Journal
Bernard Cheung – Editor-in-Chief
Impact Factor 4.973
Health Policy and Technology
Ken Redekop – Editor-in-Chief
Impact Factor 5.221
_____________________________________________________
Professor Allister Vale, President is a consultant clinical pharmacologist and toxicologist and former Director of the National Poisons Information Service (Birmingham Unit) and the West Midlands Poisons Unit, City Hospital, Birmingham, UK. He holds a professorial appointment in the University of Birmingham. He has served as President of the British Toxicology Society, of the European Association of Poisons Centres and Clinical Toxicologists and of the Clinical and Translational Toxicology Specialty Section of the Society of Toxicology. He has also been a Trustee of the American Academy of Clinical Toxicology for six years and was awarded the Academy’s Lifetime Achievement Award in 2009, the only non-North American to be so honoured. He is a former Medical Director of the MRCP(UK) Examination and a Censor of the Royal College of Physicians. He is Editor-in-Chief of Clinical Toxicology.
Dr Timothy RJ Nicholson, Honorary Secretary is a Reader in Neuropsychiatry at the Institute of Psychiatry in London. He is also an Honorary consultant Neuropsychiatrist at the South London and Maudsley NHS Foundation Trust. He runs a specialist neuropsychiatry clinics at the Department of Psychological Medicine in King’s College Hospital. He is also involved in developing and standardising outcome measures for a range of neuropsychiatric disorders both for use in research & clinical practice. He is author of the Pocket Prescriber, now in its 8th edition and Pocket Prescriber Psychiatry, in its 2nd edition, which are concise paper and electronic guides to safe and effective prescribing for junior doctors, medical students and nurse and pharmacist prescribers.
Professor Albert Ferro, Honorary Treasurer is a Clinical Pharmacologist at King’s College London. His research has focused primarily on understanding vascular endothelial and platelet function, with particular reference to the L-arginine / nitric oxide system, both in health and in patients with cardiovascular disease states. He is ex-Vice-President (2005-2007) of the British Pharmacological Society (Clinical Section) and was Chair of the London Hypertension Society between 2005 and 2009, of which he remains a committee member. He is Treasurer of the London Vascular Biology Forum (2005 onwards).
Mr Wade Dimitri is a cardiac surgeon. He is a member of several Cardiac Surgical Societies including The Society for Cardiothoracic Surgery in Great Britain and Ireland, The Society of Thoracic Surgeons (USA), Scottish Cardiac Society, The Egyptian Society Of Cardiovascular and Thoracic Surgery and an Honorary fellow of The Indian Society Of Cardiovascular and Thoracic Surgeons. Since retiring from active clinical work, he has increased his involvement with overseas training, teaching cardiac surgeons as well as operating. He went to De La Salle school in Alexandria, Egypt and graduated from Alexandria University Medical School in 1969 with an Honours degree. His entire postgraduate training was acquired in the UK. This included several rotational posts in Cardiac surgery in major London Teaching Hospitals leading to his appointment as Senior Lecturer and Honorary Consultant in Glasgow then NHS Consultant at the University Hospital in Coventry.
Professor Sir Peter Barnes FRS has been Margaret Turner-Warwick Professor of Medicine at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London since 1987. His research is focused on cellular and molecular mechanisms of asthma and COPD, understanding and developing therapies and research into biomarkers for these diseases. He is involved in multidisciplinary translational research which integrates basic science with clinical studies, thereby providing novel insights into common airway diseases. He qualified at Cambridge and Oxford Universities (first class honours). He has published over 1000 peer-review papers on asthma, COPD and related topics and has edited over 40 books (h-index = 153). He is also amongst the top 50 most highly cited researchers in the world and has been the most highly cited clinical scientist in the UK and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He has been a member of the Scientific Committee of global guidelines on asthma (GINA) and COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest, Journal of COPD Foundation, Respiratory Editor of PLoS Medicine and Editor in Chief of Up-to-Date Pulmonary Diseases. He has given several prestigious lectures, including the Amberson Lecture at the American Thoracic Society, the Sadoul Lecture at the European Respiratory Society and the Croonian Lecture at the Royal College of Physicians. He has received honorary MD degrees from the Universities of Ferrara (Italy), Athens (Greece), Tampere (Finland) and Leuven (Belgium). He is an Emeritus NIHR Senior Investigator, a Master Fellow of the American College of Chest Physicians and a member of the Academia Europaea. He was President of the European Respiratory Society 2013/14. He co-founded Imperial spin-out company RespiVert, which was acquired by Johnson & Johnson and has developed novel inhaled treatments for COPD and severe asthma
Professor Bernard Cheung, PMJ Editor-in-Chief is the Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics and heads the Division of Clinical Pharmacology and Therapeutics in the Department of Medicine of the University of Hong Kong. Professor Cheung is an Honorary Consultant Physician of Queen Mary Hospital and the Medical Director of the Phase 1 Clinical Trials Centre. He is also the Director of the Institute of Cardiovascular Science and Medicine, and the President of the Hong Kong Pharmacology Society. Professor Cheung read Medicine at Magdalene College, Cambridge. He was a British Heart Foundation Junior Research Fellow at Cambridge before taking up lectureships at the University of Sheffield and the University of Hong Kong. In 2007-2009, he held the chair in Clinical Pharmacology and Therapeutics at the University of Birmingham, England.
Jan Willem F Elte is an internist-endocrinologist, Fellow of the Royal College of Physicians (FRCP), the American College of Physicians (FACP), the Fellowship of Postgraduate Medicine (London) and European Federation of Internal Medicine (EFIM: Hon). He is (co-) author and editor of publications and books on thyroid, diabetes, obesity, organization of Internal Medicine and differential diagnosis. Dr Elte is a member of the European Board of Internal Medicine, Secretary General of the Foundation for the Development of Internal Medicine in Europe, and a European Medicines Agency Scientific Committee member and expert as an EFIM delegate. He worked in the Sint Franciscus Gasthuis, Rotterdam 1987-2011 (Deputy Head of Training 1991-2006), and 2012-2014 in the Groene Hart Ziekenhuis, Gouda. He was Secretary of the Section of Endocrinology of the NIV (Neth.Ass.Int.Med.) and former Treasurer of the NIV, AEMI (also President of Young AEMIE) and EFIM. He was a Member of the European Board of Endocrinology and Secretary General of the European Federation of Internal Medicine (EFIM) and co-director of the European School of Internal Medicine 2017-2019. He has been a member of the Editorial Boards of The European Journal of Internal Medicine (Founding Deputy Editor), The Postgraduate Medical Journal, Clinical Medicine and Internisten Vademecum (NL). At his retirement in 2011 he was knighted and became Honorary Member of the NIV.Professor Albert Ferro
Ken Redekop PhD, HPT Editor-in-Chief is an associate professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature. Current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice. Most studies relate to diabetes, cardiovascular disease, and cancer, and most involve modelling and evidence synthesis.
Dr Kerri Baker is a Consultant and previous Clinical Lead in Acute Medicine in NHS Fife. She is the Dean of Education for the Royal College of Physicians of Edinburgh, overseeing an educational programme serving almost 15000 clinicians in over 120 counties. She also works for NHS Education for Scotland as the national Associate Postgraduate Dean for stage 2 Internal Medicine training across Scotland, as well as the regional Training Programme Director for Internal Medicine training (IMT) in South East Scotland. She serves as the only non-US Board member and trustee of the Society of Bedside Medicine, and is an Invited Fellow of the American College of Physicians
Dr Neil Dewhurst is a retired physician. He trained in Edinburgh and was appointed as Consultant Cardiologist and General Physician to South Devon NHS Trust (1987 – 1995) and thereafter to NHS Tayside (1995 – 2013). He was Honorary Senior Lecturer in Medicine, Dundee University and in 2000 became the Registrar of the Royal College of Physicians of Edinburgh. In 2007 he was appointed Medical Director of MRCP(UK). In 2010 he was elected as President of the Royal College of Physicians of Edinburgh (2010-2014) and in his final presidential year chaired the Federation of Medical Royal Colleges of Physicians.
Dr Helen Oxenham has worked as a cardiology consultant since 2006. She qualified as a doctor in 1989 and trained and worked in Edinburgh until moving to North Tees and Hartlepool NHS Trust in 2010. She specialises in cardiac imaging and valvular heart disease and has an interest in adult congenital heart disease. As lead clinician for the echo service, she implemented improvement and service expansion, which has achieved British Society of Echo Departmental Accreditation for Transthoracic, Tranoesophageal echo and Training since 2016. She has helped develop and expand the Cardiac CT service in Teesside, which received the Heart Flow excellence award 2024. In 2000, she worked with the University of Auckland, New Zealand and the National Institute of Sports Excellence to complete her MD Thesis, which examined the assessment of and changes in diastolic function using Cardiac MRI with tagging and the effect of exercise training in older adults. She recently published work examining the management of cardiotoxicity secondary to chemotherapy and has regularly presented at regional and national cardiovascular meetings. She also runs regular echo training courses, is involved in developing cardiac surgery services in Ghana and has 3 grown up children and twin granddaughters.
thefpm.org.uk 